Net profit of Jagsonpal Pharmaceuticals rose 707.83% to Rs 31.99 crore in the quarter ended December 2024 as against Rs 3.96 crore during the previous quarter ended December 2023. Sales rose 56.74% to Rs 74.03 crore in the quarter ended December 2024 as against Rs 47.23 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 74.03 | 47.23 | 57 |
OPM % | 21.38 | 7.18 | - |
PBDT | 17.90 | 5.68 | 215 |
PBT | 15.49 | 5.27 | 194 |
NP | 31.99 | 3.96 | 708 |